The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HER2 amplification as a ‘molecular bait’ for trastuzumab-emtansine (T-DM1) precision chemotherapy to overcome anti-HER2 resistance in HER2 positive metastatic colorectal cancer: The HERACLES-RESCUE trial.
 
Salvatore Siena
No Relationships to Disclose
 
Alberto Bardelli
Stock and Other Ownership Interests - Horizon Discovery
Consulting or Advisory Role - Biocartis; Horizon Discovery; Trovagene
 
Andrea Sartore-Bianchi
No Relationships to Disclose
 
Cosimo Martino
No Relationships to Disclose
 
Giulia Siravegna
No Relationships to Disclose
 
Alessandro Magri'
No Relationships to Disclose
 
Francesco Leone
No Relationships to Disclose
 
Vittorina Zagonel
No Relationships to Disclose
 
Sara Lonardi
No Relationships to Disclose
 
Alessio Amatu
Consulting or Advisory Role - Amgen; Lilly
Travel, Accommodations, Expenses - Amgen; Roche
 
Federica Tosi
No Relationships to Disclose
 
Patrizia Racca
No Relationships to Disclose
 
Agostino Ponzetti
No Relationships to Disclose
 
Fortunato Ciardiello
No Relationships to Disclose
 
Silvia Marsoni
No Relationships to Disclose